Skip to main content
Dana Rathkopf, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

DanaERathkopfMD

Oncology New York, NY

Genitourinary Oncology

Associate Professor, Medicine, Memorial Sloan Kettering Cancer Center

Overview of Dr. Rathkopf

Dr. Dana Rathkopf is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. She received her medical degree from Tulane University School of Medicine and has been in practice 19 years. Dr. Rathkopf accepts several types of health insurance, listed below. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 368 doctors at New York-Presbyterian Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1998 - 2002
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2000 - 2025
  • CT State Medical License
    CT State Medical License 2023 - 2024
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • An open label phase 1/2A study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in pati... 
    2019 ASCO Annual Meeting - 6/1/2019
  • c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate Cancers
    New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate CancersSeptember 16th, 2019
  • Prostate Cancer Clinical Trial: What to Expect
    Prostate Cancer Clinical Trial: What to ExpectJune 9th, 2016
  • Wiz Lighting Troubleshooting
    Wiz Lighting TroubleshootingJune 29th, 2021
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Minnesota Blue Cross Accord
    BCBS New Mexico PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Lovelace Health Plan PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    Presbyterian Commercial
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment